Top

Published in:

01-02-2019 | Smoking and Nicotine Detoxification

Smoking cessation attitudes and practices among cancer survivors – United States, 2015

Authors: M. Shayne Gallaway, Rebecca Glover-Kudon, Behnoosh Momin, Mary Puckett, Natasha Buchanan Lunsford, Kathleen R. Ragan, Elizabeth A. Rohan, Stephen Babb

Published in: Journal of Cancer Survivorship | Issue 1/2019

Abstract

Purpose

The prevalence of smoking among cancer survivors is similar to the general population. However, there is little evidence on the prevalence of specific smoking cessation behaviors among adult cancer survivors.

Methods

The 2015 National Health Interview Survey (NHIS) data were analyzed to examine the prevalence of smoking cessation behaviors and use of treatments among cancer survivors. Weighted self-reported prevalence estimates and 95% confidence intervals were calculated using a sample of 2527 cancer survivors.

Results

Among this sample of US cancer survivors, 12% were current smokers, 37% were former smokers, and 51% were never smokers. Compared with former and never smokers, current smokers were younger (< 65 years), less educated, and less likely to report being insured or Medicaid health insurance (p < 0.01). More males were former smokers than current or never smokers. Current smokers reported wanting to quit (57%), a past year quit attempt (49%), or a health professional advised them to quit (66%). Current smokers reported the use of smoking cessation counseling (8%) or medication (38%).

Conclusions

Even after a cancer diagnosis, about one in eight cancer survivors continued to smoke. All could have received advice to quit smoking by a health professional, but a third did not.

Implications for Cancer Survivors

Health professionals could consistently advise cancer survivors about the increased risks associated with continued smoking, provide them with cessation counseling and medications, refer them to other free cessation resources, and inform them of cessation treatments covered by their health insurance.

U.S. Department of Health and Human Services. The health consequences of smoking: 50 years of progress: a report of the surgeon general. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.

Henley SJ, Thomas C, Sharapova S, Momin B, Massetti G, Winn D, et al. Vital signs: disparities in tobacco-related cancer incidence and mortality—United States, 2004–2013. MMWR Morb Mortal Wkly Rep. 2016;65(44):1212–8.CrossRefPubMed

US Cancer Statistics Working Group. United States cancer statistics: 1999–2013 incidence and mortality web-based report. Atlanta: U.S. Department of Health and Human Services, CDC, National Cancer Institute; 2016.

Emmons K, Li F, Whitton J, Mertens A, Hutchinson R, Diller L, et al. Predictors of smoking initiation and cessation among childhood cancer survivors: a report from the childhood cancer survivor study. J Clin Oncol. 2002;20(6):1608–16.CrossRefPubMed

Cox L, Africano N, Tercyak K, Taylor K. Nicotine dependence treatment for patients with cancer. Cancer. 2003;98(3):632–44.CrossRefPubMed

Tyc VL. A comparison of tobacco-related risk factors between adolescents with and without cancer. J Pediatr Psychol. 2005;30(4):359–70.CrossRefPubMed

Underwood JM, Townsend J, Tai E, White A, Davis S, Fairley T. Persistent cigarette smoking and other tobacco use after a tobacco-related cancer diagnosis. J Cancer Surviv. 2012;6(3):333–44.CrossRefPubMedPubMedCentral

Shoemaker M, White M, Hawkins N, Hayes N. Prevalence of smoking and obesity among U.S. cancer survivors: estimates from the National Health Interview Survey, 2008–2012. Oncol Nurs Forum. 2016;43(4):436–41.CrossRefPubMedPubMedCentral

Ramaswamy AT, Toll B, Chagpar A, Judson B. Smoking, cessation, and cessation counseling in patients with cancer: a population-based analysis. Cancer. 2016;122(8):1247–53.CrossRefPubMed

10.

Mayer DK, Carlson J. Smoking patterns in cancer survivors. Nicotine Tob Res. 2011;13(1):34–40. https://doi.org/10.1093/ntr/ntq199.CrossRefPubMed

11.

Park B, Kong SY, Kim J, Kim Y, Park IH, Jung SY, et al. Health behaviors of cancer survivors in nationwide cross-sectional survey in Korea: higher alcohol drinking, lower smoking, and physical inactivity pattern in survivors with higher household income. Medicine (Baltimore). 2015;94(31):e1214. https://doi.org/10.1097/MD.0000000000001214.CrossRef

12.

Tseng TS, Lin HY, Martin MY, Chen T, Partridge EE. Disparities in smoking and cessation status among cancer survivors and non-cancer individuals: a population-based study from National Health and Nutrition Examination Survey. J Cancer Surviv. 2010;4(4):313–21. https://doi.org/10.1007/s11764-010-0127-9.CrossRefPubMed

13.

Tseng TS, Lin HY, Moody-Thomas S, Martin M, Chen T. Who tended to continue smoking after cancer diagnosis: the national health and nutrition examination survey 1999-2008. BMC Public Health. 2012;12:784. https://doi.org/10.1186/1471-2458-12-784.CrossRefPubMedPubMedCentral

14.

Westmaas JL, Alcaraz KI, Berg CJ, Stein KD. Prevalence and correlates of smoking and cessation-related behavior among survivors of ten cancers: findings from a nationwide survey nine years after diagnosis. Cancer Epidemiol Biomark Prev. 2014;23(9):1783–92. https://doi.org/10.1158/1055-9965.EPI-14-0046.CrossRef

15.

Wang Z, McLoone P, Morrison DS. Diet, exercise, obesity, smoking and alcohol consumption in cancer survivors and the general population: a comparative study of 16 282 individuals. Br J Cancer. 2015;112(3):572–5. https://doi.org/10.1038/bjc.2014.598.CrossRefPubMed

16.

Division of Cancer Prevention and Control Centers for Disease Control and Prevention. National Comprehensive Cancer Control Program (NCCCP). 2017. https://www.cdc.gov/cancer/ncccp/. Accessed 3 April 2017.

17.

Klosky JL, Tyc V, Garces Webb D, Buscemi J, Klesges R, Hudson M. Emerging issues in smoking among adolescent and adult cancer survivors. Cancer. 2007;110(11):2408–19.CrossRefPubMed

18.

Mackenbach JP. Determinants of levels and changes of physical functioning in chronically ill persons: results from the GLOBE Study. J Epidemiol Community Health. 2001;55(9):631–8.CrossRefPubMedPubMedCentral

19.

Mariotto A. Multiple cancer prevalence: a growing challenge in long-term survivorship. Cancer Epidemiol Biomark Prev. 2007;16(3):566–71.CrossRef

20.

Richardson GE. Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann Intern Med. 1993;119(5):383–90.CrossRefPubMed

21.

Des Rochers C, Dische S, Saunders MI. The problem of cigarette smoking in radiotherapy for cancer in the head and neck. Clin Oncol. 1992;4(4):214–6.CrossRef

22.

Gritz E. Smoking, the missing drug interaction in clinical trials: ignoring the obvious. Cancer Epidemiol Biomark Prev. 2005;14(10):2287–93.CrossRef

23.

Browman GP, Wong G, Hodson I, Sathya J, Russell R, McAlpine L, et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med. 1993;328(3):159–63. https://doi.org/10.1056/NEJM199301213280302.CrossRefPubMed

24.

Blum A. Cancer prevention: preventing tobacco-related cancers. In: Devita VTHS, Rosenberg SA, editors. Cancer: principles and practice of oncology. Philadelphia: Lippincott-Raven Publishers; 1997. p. 545–57.

25.

Day GL. Second cancers following oral and pharyngeal cancers: role of tobacco and alcohol. J Natl Cancer Inst. 1994;86(2):131–7.CrossRefPubMed

26.

Do KA, Johnson M, Doherty D, Lee JJ, Wu X, Dong Q, et al. Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States). Cancer Causes Control. 2003;14(2):131–8.CrossRefPubMed

27.

Khuri FR, Lee JJ, Lippman SM, Kim ES, Cooper JS, Benner SE, et al. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients. J Natl Cancer Inst. 2006;98(7):441–50.CrossRefPubMed

28.

Wynder E. Tobacco and alcohol consumption in relation to the development of multiple primary cancers. Cancer. 1977;40(S4):1872–8.CrossRefPubMed

29.

Shiels MS, Gibson T, Sampson J, Alabanes D, Andreotti G, Freeman LB, et al. Cigarette smoking prior to first cancer and risk of second smoking-associated cancers among survivors of bladder, kidney, head and neck, and stage I lung cancers. J Clin Oncol. 2014;32(35):3989–95. https://doi.org/10.1200/JCO.2014.56.8220.CrossRefPubMedPubMedCentral

30.

Gan SJ, Dahlstrom K, Peck B, Caywood W, Li G, Wei Q, et al. Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers. Cancer. 2013;119(14):2593–601.CrossRefPubMedPubMedCentral

31.

Al-Mamgani A, van Rooij PH, Mehilal R, Verduijn GM, Tans L, Kwa SL. Radiotherapy for T1a glottic cancer: the influence of smoking cessation and fractionation schedule of radiotherapy. Eur Arch Otorhinolaryngol. 2014;271(1):125–32. https://doi.org/10.1007/s00405-013-2608-8.CrossRefPubMed

32.

Browman GP, Mohide EA, Willan A, Hodson I, Wong G, Grimard L, et al. Association between smoking during radiotherapy and prognosis in head and neck cancer: a follow-up study. Head Neck. 2002;24(12):1031–7. https://doi.org/10.1002/hed.10168.CrossRefPubMed

33.

Chen H, Huang X, Guo X, Mailman RB, Park Y, Kamel F, et al. Smoking duration, intensity, and risk of Parkinson disease. Neurology. 2010;74(11):878–84. https://doi.org/10.1212/WNL.0b013e3181d55f38.CrossRefPubMedPubMedCentral

34.

Choi SH, Terrell JE, Bradford CR, Ghanem T, Spector ME, Wolf GT, et al. Does quitting smoking make a difference among newly diagnosed head and neck cancer patients? Nicotine Tob Res. 2016;18(12):2216–24. https://doi.org/10.1093/ntr/ntw189.CrossRefPubMedPubMedCentral

35.

Dobson Amato KA, Hyland A, Reed R, Mahoney MC, Marshall J, Giovino G, et al. Tobacco cessation may improve lung cancer patient survival. J Thorac Oncol. 2015;10(7):1014–9. https://doi.org/10.1097/JTO.0000000000000578.CrossRefPubMedPubMedCentral

36.

Passarelli MN, Newcomb PA, Hampton JM, Trentham-Dietz A, Titus LJ, Egan KM, et al. Cigarette smoking before and after breast cancer diagnosis: mortality from breast cancer and smoking-related diseases. J Clin Oncol. 2016;34(12):1315–22. https://doi.org/10.1200/JCO.2015.63.9328.CrossRefPubMedPubMedCentral

37.

Roach MC, Rehman S, DeWees TA, Abraham CD, Bradley JD, Robinson CG. It’s never too late: smoking cessation after stereotactic body radiation therapy for non-small cell lung carcinoma improves overall survival. Pract Radiat Oncol. 2016;6(1):12–8. https://doi.org/10.1016/j.prro.2015.09.005.CrossRefPubMed

38.

Sandoval M, Font R, Manos M, Dicenta M, Quintana MJ, Bosch FX, et al. The role of vegetable and fruit consumption and other habits on survival following the diagnosis of oral cancer: a prospective study in Spain. Int J Oral Maxillofac Surg. 2009;38(1):31–9. https://doi.org/10.1016/j.ijom.2008.09.004.CrossRefPubMed

39.

Sardari Nia P, Weyler J, Colpaert C, Vermeulen P, Van Marck E, Van Schil P. Prognostic value of smoking status in operated non-small cell lung cancer. Lung Cancer. 2005;47(3):351–9. https://doi.org/10.1016/j.lungcan.2004.08.011.CrossRefPubMed

40.

Tao L, Wang R, Gao YT, Yuan JM. Impact of postdiagnosis smoking on long-term survival of cancer patients: the Shanghai cohort study. Cancer Epidemiol Biomark Prev. 2013;22(12):2404–11. https://doi.org/10.1158/1055-9965.EPI-13-0805-T.CrossRef

41.

Siu AL. Behavioral and pharmacotherapy interventions for tobacco smoking cessation in adults, including pregnant women: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015;163(8):622–34.CrossRefPubMed

42.

Fiore MC, Jaen CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ et al. Treating tobacco use and dependence: 2008 update. Clinical practice guideline. Rockville: US Department of Health and Human Services, Public Health Service; 2008.

43.

Cahill K, Stead L, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews, the Cochrane Library. 1996(1).

44.

Lancaster T, Stead L. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev Cochrane Lib. 1996;(2).

45.

Silagy C. Nicotine replacement therapies in smoking cessation. Biomed Pharmacother. 1994;48(8–9):407–8.CrossRef

46.

Babb S. Quitting smoking among adults—United States, 2000–2015. Morb Mortal Wkly Rep. 2017;65(52):1457–64.CrossRef

47.

Gritz ER, Fingeret M, Vidrine D, Lazev A, Mehta N, Reece G. Successes and failures of the teachable moment. Cancer. 2006;106(1):17–27.CrossRefPubMed

48.

National Center for Health Statistics. National Health Interview Survey 2015. National Center for Health Statistics. http://www.cdc.gov/nchs/nhis/quest_data_related_1997_forward.htm.2016. Accessed 1 March 2017.

49.

Centers for Disease Control and Prevention. Current cigarette smoking among adults in the United States. Atlanta, Georgia; 2016. https://www.cdc.gov/tobacco/data_statistics/fact_sheets/adult_data/cig_smoking/index.htm. Accessed 17 Oct 2017.

50.

Berg CJ, Thomas A, Mertens A, Schauer G, Pinsker E, Ahluwalia J, et al. Correlates of continued smoking versus cessation among survivors of smoking-related cancers. Psycho-Oncology. 2013;22(4):799–806.CrossRefPubMed

51.

Chaturvedi AK, Engels EA, Gilbert ES, Chen BE, Storm H, Lynch CF, et al. Second cancers among 104760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst. 2007;99(21):1634–43.CrossRefPubMed

52.

Coups E, Ostroff J. A population-based estimate of the prevalence of behavioral risk factors among adult cancer survivors and noncancer controls. Prev Med. 2005;40(6):702–11.CrossRefPubMed

53.

Shields PG. Smoking cessation, version 1.2016 clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2016;14(11):1430–68.CrossRef

54.

Japuntich S, Luberto C, Streck J, Rigotti N, Temel J, Lanuti M, et al. Integrating tobacco treatment into thoracic oncology settings: lessons learned. J Health Psychol. 2016;21(12):2813–23.CrossRefPubMed

55.

Lucchiari C, Masiero M, Botturi A, Pravettoni G. Helping patients to reduce tobacco consumption in oncology: a narrative review. Springerplus. 2016;5(1):1–18.CrossRef

56.

Pommeranke A, Alberg A, Brandon T, Croghan I, Cummings KM, Dresler C, et al. Physician preferences in tobacco cessation support for cancer patients: a survey of National Cancer Institute Designated Cancer Centers. San Diego: American Association for Cancer Research; 2014.

57.

Warren GW, Marshall JR, Cummings KM, Toll B, Gritz ER, Hutson A, et al. Practice patterns and perceptions of thoracic oncology providers on tobacco use and cessation in cancer patients. J Thorac Oncol. 2013;8(5):543–8. https://doi.org/10.1097/JTO.0b013e318288dc96.CrossRefPubMedPubMedCentral

58.

Warren GW, Marshall JR, Cummings KM, Toll BA, Gritz ER, Hutson A, et al. Addressing tobacco use in patients with cancer: a survey of American Society of Clinical Oncology members. J Oncol Pract. 2013;9(5):258–62. https://doi.org/10.1200/JOP.2013.001025.CrossRefPubMedPubMedCentral

59.

Sabatino S. Provider counseling about health behaviors among cancer survivors in the United States. J Clin Oncol. 2007;25(15):2100–6.CrossRefPubMed

60.

Weaver KE, Danhauer SC, Tooze JA, Blackstock AW, Spangler J, Thomas L, et al. Smoking cessation counseling beliefs and behaviors of outpatient oncology providers. Oncologist. 2012;17(3):455–62.CrossRefPubMedPubMedCentral

61.

Coups EJ, Coups E, Dhingra L, Heckman C, Manne S. Receipt of provider advice for smoking cessation and use of smoking cessation treatments among cancer survivors. J Gen Intern Med. 2009;24(S2):480–6.CrossRefPubMedCentral

62.

Sarna L. Tobacco interventions by oncology nurses in clinical practice. Cancer. 2000;89(4):881–9.CrossRefPubMed

63.

Fiore M. Treating tobacco use and dependence: 2008 guidelines. United States Tobacco Use and Dependence Guideline Panel; 2008.

64.

Maguire CP, Ryan J, Kelly A, O’Neill D, Coakley D, Walsh JB. Do patient age and medical condition influence medical advice to stop smoking? Age Ageing. 2000;29(3):264–6.CrossRefPubMed

65.

Edwards SA, Bondy S, Callaghan R, Mann R. Prevalence of unassisted quit attempts in population-based studies: a systematic review of the literature. Addict Behav. 2014;39(3):512–9.CrossRefPubMed

66.

Malarcher A. Quitting smoking among adults—United States, 2001-2010. JAMA. 2011;306(23):2554.

67.

Blair NA, Husten CG, Mariolis P, Pechacek TF, Starr G, Centers for Disease Control and Prevention (U.S.) et al. Best practices for comprehensive tobacco control programs. [Atlanta, GA]: U.S. Dept. of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office of Smoking and Health; 2007.

68.

National Cancer Institute. Cancer Center Cessation Initiative. 2018. https://cancercontrol.cancer.gov/brp/tcrb/cessation-initiative.html. Accessed 21 Oct 2018.

69.

Patrick D. The validity of self-reported smoking: a review and meta-analysis. Am J Public Health. 1994;84(7):1086–93.CrossRefPubMedPubMedCentral

70.

Comprehensive Cancer Control National Partnership. Increase availability of tobacco cessation services for cancer survivors. 2016. http://www.cccnationalpartners.org/increase-availability-tobacco-cessation-services-cancer-survivors. Accessed 3 Aug 2017.

Title: Smoking cessation attitudes and practices among cancer survivors – United States, 2015
Authors: M. Shayne Gallaway
Rebecca Glover-Kudon
Behnoosh Momin
Mary Puckett
Natasha Buchanan Lunsford
Kathleen R. Ragan
Elizabeth A. Rohan
Stephen Babb
Publication date: 01-02-2019
Publisher: Springer US
Keyword: Smoking and Nicotine Detoxification
Published in: Journal of Cancer Survivorship / Issue 1/2019
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI: https://doi.org/10.1007/s11764-018-0728-2

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Implications for Cancer Survivors

Please log in to get access to this content

Other articles of this Issue 1/2019

Financial toxicity is more than costs of care: the relationship between employment and financial toxicity in long-term cancer survivors

Living with and beyond cancer with comorbid illness: a qualitative systematic review and evidence synthesis

Integrating self-management into daily life following primary treatment: head and neck cancer survivors’ perspectives

The effectiveness of mHealth for self-management in improving pain, psychological distress, fatigue, and sleep in cancer survivors: a systematic review

A systematic review of the feasibility, acceptability, and efficacy of online supportive care interventions targeting men with a history of prostate cancer

Unpacking the layers: a meta-ethnography of cancer survivors’ loneliness

Keynote webinar | Spotlight on antibody–drug conjugates in cancer